Skip to main content
Premium Trial:

Request an Annual Quote

Elliott Knox, Peter Blecher, Maggi Blakebrough, Farfield Sensors, Benjamin Bulkley, David Page, Cellectricon, BD Biosciences

Premium

Migrations

Microbix said last week that Elliott Knox, a director since 2000, is stepping down from the board of directors. Peter Blecher has been appointed to take his place.

Blecher is the founder and former CEO of Sequent Biotechnologies, a private biotech firm that Microbix acquired in Sept. 2005. Blecher is an emergency trauma physician at Lakeridge Health hospital in Canada. He is a graduate of McGill University.


Maggi Blakebrough has joined Farfield Sensors as marketing executive, the UK-based company said last week.

Blakebrough has a strong academic background in molecular biology and a 10-year track record in scientific instrumentation combined with extensive experience in sales and customer relations, Farfield said.


California Healthcare Institute elected Benjamin Bulkley, Invitrogen's president of commercial operations, to its board of directors, the non-profit public policy research organization said recently.

Bulkley joined Invitrogen in October of 2003. Prior to Invitrogen, he held leadership positions at General Electric, most recently as vice president of global services. He received his BS from the University of Connecticut, and an MS in systems engineering from Gannon University.


The Whitehead Institute's board of directors elected faculty member David Page as the institute's fourth director, Whitehead said recently.

Page was appointed as interim director in December 2004.

A biology professor at Massachusetts Institute of Technology, Page graduated from Harvard Medical School and the Harvard-MIT Health Sciences and Technology Program in 1984 with a concentration in genetics. He came to Whitehead as one of the institute's first fellows in 1984 and became a faculty member in 1986.

Page received the MacArthur Foundation Prize Fellowship in 1986, the Searle Scholar's Award in 1989, the Amory Prize from the American Academy of Arts and Sciences in 1997, and the Curt Stern Award from the American Society of Human Genetics in 2003.

 

Products

Cellectricon last week launched the Cellaxess CX1 and CX3 systems for adherent cell electroporation based on Cellectricon's capillary electroporation technology.

Cellaxess CX1 is a micromanipulator-based system for precise targeting of distinct areas directly in cell culture dishes, Cellectricon said. CX1 installs on inverted microscopes and enables instant read-out following electroporation, the company said.

The CX3 is a parallel three-channel system designed for electroporation in 96-well plates, or 35-mm-or-larger cell culture dishes. Both systems are designed for direct transfection of adherent cell cultures and are suitable for hard-to-transfect cells such as primary cells and stem cells, Cellectricon said.


BD Biosciences has introduced two new calcium assay kits for detecting calcium flux in living cells, the company said last week.

The proprietary formulations combine a non-fluorescent calcium indicator that becomes activated inside the cell, and a signal enhancer, to provide a no-wash assay format with increased signal to background, BD said.